The taxol pharmacophore and the T-Taxol bridging principle

Cell Cycle

Volumn 4, Issue 2, 2005, Pages 278-288

  Kingston, David G I ^a   Bane, Susan ^b   Snyder, James P ^c  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b BINGHAMTON UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Docetaxel; Molecular modeling; Paclitaxel; Taxol; Tubulin

Indexed keywords

BETA TUBULIN; DOCETAXEL; PACLITAXEL; PACLITAXEL DERIVATIVE;

BINDING SITE; CONFORMATION; CRYSTALLOGRAPHY; DRUG STRUCTURE; HUMAN; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHARMACOPHORE; PHOTOAFFINITY LABELING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

EID: 24944590338     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.2.1408     Document Type: Review

References (72)

1. Mekhail T, Markman M, Paclitaxel in cancer therapy, Expert Opin Pharmacother 2002; 3:755-66.
2. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004; 4; 253-265.
3. Nogales E, Structural insight into microtubule function. Ann Rev Biophys Biomol Struc 2001; 30; 397-420.
4. Jordan MA et al., Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci 1993; 90: 9552.
5. Long BH, Fairchild CR. Paclitaxel Inhibits Progression of Mitotic Cells to G1 Phase by Interference with Spindle Formation Without Affecting Other Microtubule Functions During Anaphase and Telephase. Cancer Res 1994;54:4355-61.
6. Haldar S, Chintapalli J, Croce CM. Paclitaxel Induces Bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 1996;56:1253-5.
7. Carboni JM, Singh C, Tepper MA. Taxol and lipopolysaccharide activation of a murine macrophage cell line and induction of similar tyrosine phosphoproteins, J Natl Cancer Inst Monogr 1993;15:95-101.
8. Blagosklonny MV, Fojo T. Molecular effects of paclitaxel: Myths and reality (a critical review). Int J Cancer 1999;83:151-6.
9. Altmann K-H. Epothilone B and its analogs - a new family of anticancer agents. Mini Reviews in Med Chem 2003;3:149-58.
10. Kalesse M. The chemistry and biology of discodermolide. Chem Bio Chem 2000;1:171-5.
11. Lindel T, Jensen PR, Fenical W, Long BH, Casazza AM, Carboni J, Fairchild CR. Eleutherobin, a new cytotoxin that mimics paclitaxel (taxol) by stabilizing microtubules. J Am Chem Soc 1997;119: 8744-5.
12. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277; 665-7.
13. Rao S, Horwitz SB, Ringel I. Direct photoaffinity labeling of tubulin with taxol. J Natl Cancer Inst 1992; 84:785-8.
14. Rao S, Krauss NE, Heerding JM, Swindell CS, Ringel I, Orr GA, Horwitz SB. 3′-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of α,β-tubulin. J Biol Chem 1994; 269: 3132-4.
15. Rao S, Orr GA, Chaudhary AG, Kingston DGI, Horwitz SB. Characterization of the taxol binding site on the microtubule. J Biol Chem 1995; 270: 20235-8.
16. Rao S, He L, Chakravarty S, Ojima I, Orr GA, Horwitz SB. Characterization of the taxol binding site on the microtubule. J Biol Chem 1999; 274: 37990-4.
17. Nogales E, Wolf SG, Downing KH. Structure of the aβ-tubulin dimer by electron crystallography. Nature 1998; 39: 199-203.
18. Guéritte-Voegelein F, Guénard D, Mangatal L, Potier P, Guilhem J, Césario M, Pascard C. Structure of a Synthetic Taxol Precursor: N-tert-Butoxycarbonyl-10-deacetyl-N-debenzoyltaxol. Acta Cryst 1990; C46: 781-4.
19. Georg GI, Chen TT, Ojima I, Vyas DM eds. Taxane Anticancer Agents: Basic Science and Current Status (ACS Symposium Series 583). Washington, DC: American Chemical Society, 1995.
20. Wang X, Itokawa H, Lee, K-H, Structure-activity relationships of taxoids. In: Itokawa H, Lee K-H, eds Taxus: The Genus Taxus. London: Taylor & Francis, 2003:298-386.
21. Kingston DGI, Jagtap PG, Yuan H, Samala L. The chemistry of taxol and related taxoids. In: Herz W, Falk H, Kirby GW, eds. Progress in the Chemistry of Organic Natural Products Vol 84. Wien and New York: Springer, 2002: 53-224.
22. a) Czaplinski K-HA, Grunewald GL. A comparative molecular field analysis derived model of the binding of taxol analogues to microtubules. Biorg Med Chem Lett 1994;4:2211-6;
23. b) Zhu Q, Guo Z, Huang N, Wang M, Chu F. Comparative molecular field analysis of a series of paclitaxel analogues. J Med Chem 1997: 40: 4319-28;
24. c) Morita H, Gonda A, Wei L, Takeya K, Itokawa H. 3D QSAR Analysis of Taxoids from Taxus Cupidata Var. Nana by Comparative Molecular Field Approach. Bioorg Med Chem Lett 1997; 7: 2387-91;
25. d) Wang M, Xia X, Kim Y, Hwang D, Jansen JM, Botta M, Liotta DC, Snyder JP. A unified and Quantitataive Receptor Model for the Microtubule Binding of Paclitaxel and Epothilone. Org Lett 1999; 1: 43-46.
26. Mastropaolo D, Camerman A, Luo Y, Brayer GD, Camerman N. Crystal and molecular structure of paclitaxel (taxol). Proc Natl Acad Sci 1995; 92: 6920-4.
27. Vander Velde DG, Georg GI, Grunewald GL, Gunn CW, Mitscher LA. "hydrophobic collapse" of taxol and taxotere solution conformations in mixtures of water and organic solvent. J Am Chem Soc 1993; 115: 11650-1.
28. Paloma LG, Guy RK, Wrasidlo W, Nicolaou KC. Conformation of a water-soluble derivative of taxol in water by 2d-nmr spectroscopy. Chem Biol 1994; 1: 107-12.
29. Ojima I, Chakravarty S, Inoue T, Lin S, He L, Horwitz SB, Kuduk SC, Danishefsky SJ. A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc Natl Acad Sci USA1999; 96: 4256-61.
30. Ojima I, Kuduk SD, Chakravarty S, Ourevitch M, Begue J-P. A novel approach to the study of solution structures and dynamic behavior of paclitaxel and DTX using fluorine-containing analogs as probes. J Am Chem Soc 1997; 119: 5519-27.
31. Ojima I, Inoue T, Chakravarty S. Enantiopure fluorine-containing taxoids: Potent anticancer agents and versatile probes for biomedical problems. J Fluorine Chem 1999; 97: 3-10.
32. Dubois J, Guenard D, Gueritte-Voeglein F, Guedira N, Potier P, Gillet B, Betoeil J-C. Conformation of taxotere and analogues determined by NMR spectroscopy and molecular modeling studies. Tetrahedron 1993; 49: 6533-44.
33. Williams HJ, Scott AI, Dieden RA, Swindell CS, Chirlian LE, Francl MM, Heerding JM, Krauss NE. Nmr and molecular modeling study of active and inactive taxol analogues in aqueous and nonaqueous solution. Can J Chem 1994; 72: 252-60.
34. Cachau RE, Gussio R, Beutler JA, Chmurny GN, Hilton BD, Muschik GM, Erickson JW. Solution structure of taxol determined using a novel feedback-scaling procedure for noerestrained molecular dynamics. Supercomput Appl High Perform Comput 1994; 8: 24-34.
35. Moyna G, Williams HJ, Scott AI, Ringel I, Gorodetsky R, Swindell CS. Conformational studies of paclitaxel analogs modified at the C-2′ position in hydrophobic and hydrophilic solvent systems. J Med Chem 1997; 40: 3305-11.
36. Snyder JP, Nevins N, Cicero DO, Jansen J. The conformations of taxol in chloroform. J Am Chem Soc 2000; 122: 724-5.
37. Snyder, J. P.; Nevins, N.; Jimenez-Barbero, Cicero, D.; Jansen, J. M. unpublished.
38. Jimenez-Barbero J, Amat-Guerri F, Snyder JP. The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization. Curr Med Chem - Anti-Cancer Agents 2002; 2: 91-122.
39. Li Y, Poliks B, Cegelski L, Poliks M, Cryczynski Z, Piszczek G, Jagtap P, G., Studelska DR, Kingston DGI, Schaefer J, Bane S. Conformation of microtubule-bound paclitaxel determined by fluorescence spectroscopy and REDOR NMR. Biochemistry 2000; 39: 281-91.
40. Snyder JP, Nettles JH, Cornett B, Downing KH, Nogales E. The binding conformation of taxol in beta tubulin: A model based on the electron crystallographic density. Proc Natl Acad Sci USA 2001; 98: 5312-16.
41. Lowe J, Li H, Downing KH, Nogales E. Refined structure of α,β-tubulin at 3.5 Å resolution. J Mol Biol 2001; 313: 1045-57.
42. Nogales E, Whittaker M, Milligan RA, Downing KH. High-resolution model of the microtubule. Cell 1999; 96: 79-88.
43. Li H, DeRosier DJ, Nicholson WV, Nogales E, Downing KH. Microtubule structure at 8 Å resolution. Structure 2002;10:1317-28.
44. Ivery TGM, Le T. Modeling the interaction of paclitaxel with beta-tubulin. Oncology Res 2003; 14: 1-19.
45. Diaz JF, Strobe R, Engelborghs Y, Souto AA, Andreu JM. Molecular recognition of taxol by microtubules. J Biol Chem 2000; 275: 26265-76.
46. Chen S-H, Wei J-M, Long BH, Fairchild CA, Carboni J, Mamber SW, Rose WC, Johnston K, Casazza AM, Kadow JF, Farina V, Vyas D, Doyle TW. Novel C-4 paclitaxel (taxol) analogs: Potent antitumour agaents. Bioorg Med Chem Lett 1995; 5: 2741-6.
47. Chen S-H. First syntheses of C-4 methyl ether paclitaxel analogs and the unexpected reactivity of 4-deacetyl-4-methyl ether baccatin III. Tetrahedron Lett 1996; 37: 3935-8.
48. Yuan H, Kingston DGI. Synthesis and biological activity of a novel C4-C6 bridged paclitaxel analog. Tetrahedron 1999; 55: 9707-16.
49. Metaferia BB, Hoch J, Glass TE, Bane SL, Chatterjee SK, Snyder JP, Lakdawala A, Cornett B, Kingston DGI. Synthesis and biological evaluation of novel macrocyclic paclitaxel analogues. Org Lett 2001; 3: 2461-4.
50. Boge TC, Himes RH, Vander Velde DG, Georg GI. The effect of the aromatic rings of taxol on biological activity and solution conformation: Synthesis and evaluation of saturated taxol and taxotere analogues. J Med Chem 1994; 37: 3337-43.
51. Georg GI, Harriman GCB, Hepperle M, Clowers JS, Vander Velde DG, Himes RH. Synthesis, conformational analysis, and biological evaluation of heteroaromatic taxanes. J Org Chem 1996; 61: 2664-76.
52. Boge TC, Wu Z-J, Himes RH, Vander Velde DG, Georg GI. Conformationally restricted paclitaxel analogues: Macrocyclic mimics of the "hydrophobic collapse" conformation. Bioorg Med Chem Lett 1999;9:3047-52.
53. Ojima I, Chakravarty S, Inoue T, Lin S, He L, Horwitz SB, Kuduk SD, Danishefsky SJ. A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc Natl Acad Sci 1999; 96: 4256-61.
54. Ojima I, Lin S, Inoue T, Miller ML, Borella CP, Geng X, Walsh JJ. Macrocycle formation by ring-closing metathesis. Application to the syntheses of novel macrocyclic taxoids. J Am Chem Soc 2000; 122: 5343-53.
55. Ojima I, Geng X, Lin S, Pera P, Bernacki RJ. Design, synthesis and biological activity of novel C2-C3′ N-linked macrocyclic taxoids. Bioorg Med Chem Lett 2002; 12: 349-52.
56. Geng X, Miller ML, Lin S, Ojima I. Synthesis of novel C2-C3′N-linked macrocyclic taxoids by means of highly regioselective heck macrocyclization. Org Lett 2003; 5: 3733-6.
57. 50 0.060 mM).
58. Querolle O, Dubois J, Thoret S, Dupont C, Guéritte F, Guénard D. Synthesis of novel 2-O,3′-N-linked macrocyclic taxoids with variable ring size. Eur J Org Chem 2003: 542-50.
59. Querolle O, Dubois J, Thoret S, Roussi F, Montiel-Smith S, Guéritte F, Guénard D. Synthesis of novel macrocyclic docetaxel analogues. Influence of their macrocyclic ring size on tubulin activity. J Med Chem 2003; 46: 3623-30.
60. Querolle O, Dubois J, Thoret S, Roussi F, Guéritte F, Guénard D. Synthesis of C2-C3′ NLinked Macrocyclic Taxoids. Novel Docetaxel Analogs with High Tubulin Activity. J Med Chem 2004; 47: 5937-44.
61. Sun L, Geney R, Xia S, Horwitz SB, Pera P, Bernacki RJ, Ojima I. Rational design, synthesis and evaluation of conformationally restrained novel paclitaxel analogs. Abstracts, American Chemical Society National Meeting, Philadelphia, PA, August 2004. Washington: American Chemical Society, 2004: MEDI-97.
62. Kant J, Schwartz WS, Fairchild C, Gao Q, Huang S, Long BH, Kadow JF, Langley DR, Farina V, Vyas D. Diastereoselective addition of Grignard reagents to azetidine-2,3-dione: Synthesis of novel taxol analogues. Tetrahedron Lett 1996; 37: 6495-8.
63. Johnson SA, Snyder JP, unpublished.
64. Cicero DO, Barbato G, Bazzo R. NMR analysis of molecular flexibility in solution: A new method for the study of complex distributions of rapidly exchanging conformations. Application to a 13-residue peptide with an 8-residue loop. J Am Chem Soc 1995; 117: 1027-33.
65. Nevins N, Cicero D, Snyder JP. A test of the single-conformation hypothesis in the analysis of NMR data for small polar molecules: A force field comparison. J Org Chem 1999; 64: 3979-86.
66. Monteagudo E, Cicero DO, Cornett B, Myles DC, Snyder JP. The conformation of discodermolide in DMSO. J Am Chem Soc 2001; 123: 6929-30.
67. B. Cornett, Ph. D. Dissertation, Emory University (2002).
68. Barboni L, Lambertucci C, Appendino G, Vander Velde DG, Himes RH, Bombardelli E, Wang M, Snyder JP. Synthesis and NMR-driven conformational analysis of taxol analogues conformationally constrained on the C13 side chain. J Med Chem 2001: 44; 1576-87.
69. Ganesh T, Guza RC, Bane S, Ravindra R, Shanker N, Lakdawala AS, Snyder JP, Kingston DGI. The bioactive taxol Conformation on β-tubulin: Experimental evidence from highly active constrained analogs Proc Nat Acad Sci USA 2004; 101: 10006-10011.
70. Jardetzky O. On the nature of molecular conformation inferred from high-resolution NMR. Biochim Biophys Acta 1980; 621: 227-232.
71. Jardetzky O, Roberts GCK. NMR in Molecular Biology. New York: John Wiley & Sons. pp 1981: 126-140.
72. Nettles JH, Li H, Cornett B, Krahn JM, Snyder JP, Downing KH. The binding mode of epothilone A on α,β-tubulin by electron crystallography. Science 2004; 305: 866-9.